Both total and phosphorylated tau are increased in Alzheimer's disease.
about
Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studiesBiomarkers in dementia: clinical utility and new directionsTau Biology and Tau-Directed Therapies for Alzheimer's DiseaseCerebrospinal fluid biomarkers for Parkinson disease diagnosis and progressionMRI and CSF studies in the early diagnosis of Alzheimer's disease.CSF biomarkers for mild cognitive impairment.Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review.Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's diseaseImmunological memory to hyperphosphorylated tau in asymptomatic individuals.Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.Total and phosphorylated tau protein as biological markers of Alzheimer's disease.The prepared tau exon-specific antibodies revealed distinct profiles of tau in CSF of the patients with Creutzfeldt-Jakob diseaseProteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.A Pilot Longitudinal Study on Cerebrospinal Fluid (CSF) Tau Protein in Alzheimer's Disease and Vascular Dementia.Neuroproteomics as a promising tool in Parkinson's disease research.Biomarkers for cognitive impairment in Parkinson disease.Decreased level of olfactory receptors in blood cells following traumatic brain injury and potential association with tauopathyBrain atrophy in healthy aging is related to CSF levels of Aβ1-42.Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease.Emerging biomarkers in cognition.Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease.Expression of Tau40 induces activation of cultured rat microglial cells.Does CSF p-tau181 help to discriminate Alzheimer's disease from other dementias and mild cognitive impairment? A meta-analysis of the literature.CSF tau and β-amyloid as biomarkers for mild cognitive impairment.Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implicationsHyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble.CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay.Cerebrospinal fluid protein biomarkers for Alzheimer's disease.Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.Changes of Cerebrospinal Fluid Peptides due to Tauopathy.Neurochemical biomarkers in Alzheimer's disease and related disorders.Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease.Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.
P2860
Q26798325-F4CE99B1-FB7E-47F0-A698-BD49951F9F2BQ27007086-92DFB23A-4C5E-465E-99E2-35B4EB27E1F5Q28071398-A76BA6FC-B4B7-499C-9D80-9921455282C4Q30501271-2E39FAAE-9975-49D5-9448-3D59803BFC72Q30953178-691CDEA4-D71B-4FF4-88A7-DBAB59509256Q30953185-40296405-9DC3-4398-8E35-55CD995BE3DCQ30996799-D290B855-1C3F-4936-87F1-C1BFF30910FFQ31108280-A39BE1C0-465C-4D83-9DF9-F69A7B2600CCQ31146512-E08509E0-1FBC-4E94-A4A7-44EC279AD0FFQ33287487-3AC1FC75-29CF-4A65-A65D-BB40DB3CE01AQ33559360-F3FDFCBF-D925-4351-8CCB-E82D72A30E3AQ33590723-93817818-56AF-424B-A483-76674AE82614Q33624674-FC8C9423-680A-49E7-8CF4-1802B3AAC4A3Q33649832-308F3D08-8D98-4562-843A-21C292508141Q33666765-4E2937B7-3345-4BA2-8F5F-61F00C8997E0Q33695805-F5F53928-4A0A-48AF-BC56-5AA126AA3426Q33821316-051788F4-06A5-41A8-B0CB-DE01568F4F09Q33896664-0D777527-07B3-47F1-B29A-6CE028C128F9Q34317749-E9DD4A98-C20E-4D4C-A47C-952FB3206364Q34514638-1394CD47-A777-4370-832C-DC06AA17FF72Q34776835-25811B7A-E7B3-4DB6-BC3C-30DA7AC09DE1Q35005803-52183A12-799D-4F43-9BE8-DEF976E91E2BQ35008258-FD0B4485-ECF0-49E5-A89D-D1C0A2F61A01Q35014708-F80A8AAC-B0D7-40E4-AF45-9F4A85F0AFD1Q35022620-0D84D1AD-3C71-49EC-BBDE-7816197E038BQ35166684-CD88CB2D-7188-4058-A7BB-77644CE6FE80Q35236838-F460DCB6-74EF-4CBA-B433-06DF2D5D2E09Q35482194-5FD3D917-6CC2-467F-89B7-000AB5C4BB01Q35576517-8730228E-1289-4C21-A204-0B55A4920040Q35580179-CE6F8BDA-A5EB-460B-8B6A-92584CD39121Q35788903-F8B61C6E-C8BD-46C2-A039-5CEF67D4FCBCQ36045282-28AC7BFA-319E-471B-87AD-70338DEA84D9Q36157458-DA13F496-CAC0-453B-802A-1635E2615E15Q36252166-E68235A2-ADFD-4433-BF5F-7D16B6BAB7FEQ36357894-B772E8F9-41C4-4627-A0B7-E69E8BA8B74FQ36366891-974072CD-8F29-41FC-BD27-1E1FBA9F6157Q36382217-29173B59-F64B-447C-9817-8F182A7227A5Q36626657-8120BED9-5E11-4C2C-ADFB-10D33BAD5227Q36796560-282C2BE3-2AF6-4279-B875-6B33DD780A7CQ36913222-A1F429D3-1C90-45DF-A32A-8E5C63996EE2
P2860
Both total and phosphorylated tau are increased in Alzheimer's disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Both total and phosphorylated tau are increased in Alzheimer's disease.
@en
type
label
Both total and phosphorylated tau are increased in Alzheimer's disease.
@en
prefLabel
Both total and phosphorylated tau are increased in Alzheimer's disease.
@en
P2093
P2860
P50
P356
P1476
Both total and phosphorylated tau are increased in Alzheimer's disease.
@en
P2093
Davidsson P
Granérus AK
Tullberg M
Vanderstichele H
Wikkelso C
P2860
P304
P356
10.1136/JNNP.70.5.624
P407
P577
2001-05-01T00:00:00Z